title: Aspergillus fumigatus contamination of lymphokine-activated killer cells infused into cancer patients.
abstract: Lymphokine-activated killer (LAK) cells, prepared by incubating autologous lymphocytes in cell culture medium with interleukin-2, selectively lyse tumor cells and are effective immunotherapy of some cancers. During a 3-month period, two patients at our center were infused with LAK cells subsequently found to have been contaminated by Aspergillus fumigatus. Each case was investigated by obtaining environmental cultures and assessing aseptic practices during LAK cell preparation. Investigation of the first case demonstrated a malfunction of the laminar air flow hood, under which interleukin-2 and the patient's lymphocytes had been added to cell culture medium, and showed heavy A. fumigatus contamination of the hood, adjacent countertop, and cell culture incubator. Despite repair of the laminar air flow hood and cleaning of the laboratory, a second case occurred, and cultures at that time implicated the humidified cell culture incubators as the source of A. fumigatus. Following incubator sterilization and removal of the humidification apparatus from the incubators, weekly environmental cultures in the LAK cell laboratory were negative, and none of the LAK cell cultures from the 20 patients treated during the ensuing 15 months grew A. fumigatus. Our findings show that growth of fungi in humidified incubators, which previously has caused contamination problems in tissue culture and clinical microbiology laboratories, can result in patient infections when humidified incubators are used to prepare cells for reinfusion.
authors.affiliation: Department of Medicine, University of Chicago Hospitals, Illinois 60637.
authors.forename: P M
authors.initials: PM
authors.lastname: Arnow
authors.forename: S G
authors.initials: SG
authors.lastname: Houchins
authors.forename: J M
authors.initials: JM
authors.lastname: Richards
authors.forename: R
authors.initials: R
authors.lastname: Chudy
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000209:etiology*; D001232:Aspergillus fumigatus / Q000254:growth & development / Q000302:isolation & purification*; D004783:Environmental Microbiology; D005260:Female; D006801:Humans; D006813:Humidity; D007167:Immunotherapy / Q000009:adverse effects*; D007185:Incubators; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology / Q000382:microbiology*; D009369:Neoplasms / Q000628:therapy*